The New Orleans BioInnovation Center provides laboratory and office facilities, business consulting, and funding support to help Louisiana-based biotech entrepreneurs commercialize their research and develop new biotechnology companies. The organization offers state-of-the-art lab equipment, free commercialization consulting, and access to the New Orleans BioFund to support early-stage biotech innovations.

Informuta, Inc. is a startup developing a predictive diagnostic platform that uses machine learning to assess bacterial infections for antibiotic resistance and predict the likelihood of future resistance, based on research identifying a genetic "mutational signature" in bacteria like Pseudomonas aeruginosa. The company was founded by Tulane University researchers and aims to address antibiotic resistance and reduce antibiotic misuse in clinical practice.

LongueVue Capital is a New Orleans-based private equity firm founded in 2001 that invests in middle-market companies across healthcare, transportation and logistics, specialty manufacturing, and other industries, with over $1 billion in assets under management across four funds. The firm partners with entrepreneurs and management teams to provide capital and operational expertise to drive value creation in companies with $15 million or more in sales.

Revelry Venture Partners is a seed-stage venture capital firm that invests $250,000 to $500,000 in pre-seed and seed stage technology startups in the United States and Canada. The firm focuses on mission-driven founders building companies at the intersection of mission-critical workflows and emerging technologies including artificial intelligence, augmented reality, virtual reality, and blockchain.